CAR-T cells
Engineering CAR-T cells
6
Prospects for combined use of oncolytic viruses and CAR T-cells
27
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
17
New Strategies for the Treatment of Solid Tumors with CAR-T Cells
12
Incorporation of functional elements enhances the antitumor capacity of CAR T cells
5
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity
19
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity
15
The functional verification of EGFR-CAR T-cells targeted to hypopharyngeal squamous cell carcinoma
7
Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization
19
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
18
CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia
13
Patient-derived glioblastoma stem cells are killed by CD133- specific CAR T cells but induce the T cell aging marker CD57
14
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
9
Frβ-Directed Car T Cells for Immunotherapy of Cancer
214
Clinical trials of CAR-T cells in China
10
Universal CARs, universal T cells, and universal CAR T cells
9
Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
11
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses
18
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity
14
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
10